Articles dans des revues avec comité de lecture (60)
9.
Vanhaverbeke, C., Touboul, D., Elie, N., Prévost, M., Meunier, C. C., Michelland, S. S., Cunin, V. V., Ma, L., Vermijlen, D., Delporte, C., Pochet, S., Le Gouellec, A. A., Sève, M. M., Van Antwerpen, P., & Souard, F. (2021). Untargeted metabolomics approach to discriminate mistletoe commercial products. Scientific report, 11, 10.1038/s41598-021-93255-z, 14205.10.
Ma, L., Papadopoulou, M., Taton, M., Genco, F., Marchant, A., Meroni, V., & Vermijlen, D. (2021). Effector Vγ9Vδ2 T cell response to congenital Toxoplasma gondii infection. JCI insight, 6(16). doi:10.1172/jci.insight.13806611.
Mishra, A., Lai, G. C., Yao, L. J., Aung, T. T., Shental, N., Rotter-Maskowitz, A., Shepherdson, E., Singh, G. S. N., Pai, R., Shanti, A., Wong, R. M. M., Lee, A., Khyriem, C., Dutertre, C. A., Chakarov, S., Srinivasan, K., Shadan, N. B., Zhang, X.-M., Khalilnezhad, S., Cottier, F., Tan, A. S. M., Low, G., Chen, P., Fan, Y., Hor, P. X., Lee, A. K. M., Choolani, M., Vermijlen, D., Sharma, A., Fuks, G., Straussman, R., Pavelka, N., Malleret, B., McGovern, N., Albani, S., Chan, J. K. Y., & Ginhoux, F. (2021). Microbial exposure during early human development primes fetal immune cells. Cell. doi:10.1016/j.cell.2021.04.03913.
Papadopoulou, M., Dimova, T., Shey, M., Briel, L., Veldtsman, H., Khomba, N., Africa, H., Steyn, M., Hanekom, W. W., Scriba, T. T., Nemes, E., & Vermijlen, D. (2020). Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth. Proceedings of the National Academy of Sciences of the United States of America, 117(31), 18638-18648. doi:10.1073/pnas.192259511714.
Ma, L., Phalke, S. P., Stévigny, C., Souard, F., & Vermijlen, D. (2020). Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells. Cells, 9(6). doi:10.3390/cells906156015.
Tieppo, P., Papadopoulou, M., Gatti, D., McGovern, N., Chan, J. K. Y., Gosselin, F., Goetgeluk, G., Weening, K., Ma, L., Dauby, N., Cogan, A., donner, C., Ginhoux, F., Vandekerckhove, B., & Vermijlen, D. (2020). The human fetal thymus generates invariant effector γδ T cells. The Journal of experimental medicine, 217(3). doi:10.1084/jem.2019058016.
Papadopoulou, M., Tieppo, P., McGovern, N., Gosselin, F., Chan, J. K. Y., Goetgeluk, G., Dauby, N., Cogan, A., donner, C., Ginhoux, F., Vandekerckhove, B., & Vermijlen, D. (2019). TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells. The Journal of immunology. doi:10.4049/jimmunol.190059217.
Di Lorenzo, B., Simões, A. A., Caiado, F., Tieppo, P., Correia, D. D., Carvalho, T., Da Silva, M. G., Déchanet-Merville, J., Schumacher, T. T., Prinz, I., Norell, H., Ravens, S., Vermijlen, D., & Silva-Santos, B. (2019). Broad cytotoxic targeting of acute myeloid leukemia by polyclonal delta one T cells. Cancer immunology research, 7(4), 552-558. doi:10.1158/2326-6066.CIR-18-064718.
van der Heiden, M., Björkander, S., Rahman Qazi, K., Bittmann, J., Hell, L., Jenmalm, M. C., Marchini, G., Vermijlen, D., Abrahamsson, T., Nilsson, C., & Sverremark-Ekström, E. (2019). Characterization of the γδ T-cell compartment during infancy reveals clear differences between the early neonatal period and 2 years of age. Immunology and cell biology. doi:10.1111/imcb.1230320.
Polese, B., Geenen, V., Gridelet, V., Perrier D'Hauterive, S., Renard, C., Munaut, C., Martens, H., Vermijlen, D., King, I. I., & Jacobs, N. (2018). Accumulation of IL-17+ Vγ6+ γδ T cells in pregnant mice is not associated with spontaneous abortion. Clinical and Translational Immunology, 7(1), e1008. doi:10.1002/cti2.1008